JP2022546964A - Ｐｂｐ結合二環式ペプチドリガンド - Google Patents

Ｐｂｐ結合二環式ペプチドリガンド Download PDF

Info

Publication number
JP2022546964A
JP2022546964A JP2022513188A JP2022513188A JP2022546964A JP 2022546964 A JP2022546964 A JP 2022546964A JP 2022513188 A JP2022513188 A JP 2022513188A JP 2022513188 A JP2022513188 A JP 2022513188A JP 2022546964 A JP2022546964 A JP 2022546964A
Authority
JP
Japan
Prior art keywords
seq
pbp
peptide
acid
peptide ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022513188A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546964A5 (enExample
Inventor
ヴァン リーツチョーテン カテリーヌ
ベスウィック ポール
ドーソン マイク
バームフォース マシュー
スカイナー マイケル
チェン リューホン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BicycleTx Ltd
Original Assignee
BicycleTx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BicycleTx Ltd filed Critical BicycleTx Ltd
Publication of JP2022546964A publication Critical patent/JP2022546964A/ja
Publication of JP2022546964A5 publication Critical patent/JP2022546964A5/ja
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
JP2022513188A 2019-08-28 2020-08-28 Ｐｂｐ結合二環式ペプチドリガンド Ceased JP2022546964A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1912320.7A GB201912320D0 (en) 2019-08-28 2019-08-28 PBP Binding Bicyclic Peptide Ligands
GB1912320.7 2019-08-28
PCT/GB2020/052058 WO2021038232A1 (en) 2019-08-28 2020-08-28 Pbp binding bicyclic peptide ligands

Publications (2)

Publication Number Publication Date
JP2022546964A true JP2022546964A (ja) 2022-11-10
JP2022546964A5 JP2022546964A5 (enExample) 2023-09-05

Family

ID=68108985

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022513188A Ceased JP2022546964A (ja) 2019-08-28 2020-08-28 Ｐｂｐ結合二環式ペプチドリガンド

Country Status (6)

Country Link
US (1) US20220281918A1 (enExample)
EP (1) EP4021922A1 (enExample)
JP (1) JP2022546964A (enExample)
CN (1) CN114829374B (enExample)
GB (1) GB201912320D0 (enExample)
WO (1) WO2021038232A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023515567A (ja) * 2020-02-26 2023-04-13 バイスクルテクス・リミテッド Ｐｂｐ３結合二環式ペプチドリガンド

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ731185A (en) 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
WO2019002842A1 (en) 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Ｃｄ１３７に対して特異的な二環式ペプチドリガンド
CA3091775A1 (en) 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
WO2020128527A1 (en) 2018-12-21 2020-06-25 Bicyclerd Limited Bicyclic peptide ligands specific for pd-l1
EP3897849A1 (en) 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
CN116348476A (zh) 2020-08-03 2023-06-27 拜斯科技术开发有限公司 基于肽的接头
CN116802190A (zh) * 2020-11-13 2023-09-22 拜斯科技术开发有限公司 特异于转铁蛋白受体1（TfR1）的双环肽配体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
ES2428869T3 (es) 2005-01-24 2013-11-12 Pepscan Systems B.V. Compuestos de unión, compuestos inmunógenos y peptidomiméticos
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
NZ731185A (en) * 2014-10-29 2024-03-22 Bicyclerd Ltd Bicyclic peptide ligands specific for mt1-mmp
GB201706477D0 (en) * 2017-04-24 2017-06-07 Bicycle Therapeutics Ltd Modification of polypeptides
WO2019002842A1 (en) * 2017-06-26 2019-01-03 Bicyclerd Limited BICYCLIC PEPTIDE LIGANDS WITH DETECTABLE FRACTIONS AND USES THEREOF
WO2020084305A1 (en) * 2018-10-23 2020-04-30 Bicycletx Limited Bicyclic peptide ligands and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DEYLE, K. ET AL: "Phage Selection of Cyclic Peptides for Application in Research and Drug Development", ACC. CHEM. RES., vol. 50, JPN6024031671, 2017, pages 1866 - 1874, ISSN: 0005391084 *
LI, S. ET AL: "A Novel Strategy for In Vitro Selection of Peptide-Drug Conjugates", CHEMISTRY & BIOLOGY, vol. 10, JPN6024031670, 2003, pages 233 - 239, ISSN: 0005391085 *
RUDGERS, G. W. ET AL: "Binding Properties of a Peptide Derived from β-Lactamase Inhibitory Protein", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 45, no. 12, JPN6024031673, 2001, pages 3279 - 3286, ISSN: 0005391087 *
ZAPUN, A. ET AL: "Penicillin-binding proteins and β-lactam resistance", FEMS MICROBIOL REV, vol. 32, JPN6024031672, 2008, pages 361 - 385, ISSN: 0005391086 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023515567A (ja) * 2020-02-26 2023-04-13 バイスクルテクス・リミテッド Ｐｂｐ３結合二環式ペプチドリガンド

Also Published As

Publication number Publication date
US20220281918A1 (en) 2022-09-08
WO2021038232A1 (en) 2021-03-04
GB201912320D0 (en) 2019-10-09
CN114829374A (zh) 2022-07-29
CN114829374B (zh) 2025-04-04
EP4021922A1 (en) 2022-07-06

Similar Documents

Publication Publication Date Title
CN114829374B (zh) 结合pbp的双环肽配体
JP2023515567A (ja) Ｐｂｐ３結合二環式ペプチドリガンド
JP2023514791A (ja) 抗感染性二環式ペプチドコンジュゲート
JP7519358B2 (ja) Ｍｔ１－ｍｍｐに特異的な二環式ペプチドリガンド
CN113518648B (zh) Mt1-mmp特异性的双环肽配体
JP2022513806A (ja) Ｍｔ１－ｍｍｐに特異的な二環式ペプチドリガンド
CN114521197A (zh) 异串联双环肽复合物
JP2022514618A (ja) Ｐｄ－ｌ１に特異的な二環式ペプチドリガンド
JP2022518695A (ja) Ｃａｉｘに特異的な二環式ペプチドリガンド
US10654897B2 (en) β-hairpin peptidomimetics
JP2022514255A (ja) Ｐｓｍａに特異的な二環式ペプチドリガンド
JP2022517399A (ja) Ｃｄ３８に特異的な二環式ペプチドリガンド
JP2022518210A (ja) インテグリンαｖβ３に特異的な二環式ペプチドリガンド
US10829520B2 (en) Beta-hairpin peptidomimetics
CN117203219A (zh) 特异性针对p-选择素的双环肽配体
WO2021220011A1 (en) Anti-infective bicyclic peptide conjugates
EA046810B1 (ru) Бициклические пептидные лиганды, специфичные к mt1-mmp
EA046487B1 (ru) Бициклические пептидные лиганды, специфичные к mt1-mmp
US20170253634A1 (en) Beta-hairpin peptidomimetics

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230823

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230823

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240813

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241022

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250212

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250430

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20250826